RxDoctor Payments Data

Garni Barkhoudarian, MD

Neurological Surgery · Santa Monica, CANPI 1578707642

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Aesculap, Inc. at 32.8% of the total.

$52,635in general payments, 2019–2025

Across 84 payments — averaging $626.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aesculap, Inc.$17K
  • Carl Zeiss Meditec USA, Inc.$15K
  • Vascular Technology, Inc.$11K
  • Medexus Pharma, Inc.$5K
  • KARL Storz Endoscopy-america$1K
  • Zimmer Biomet$567
  • plus $3K from 22 others
$26,833in research payments, 2019–2025

Across 7 payments — averaging $3833.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corcept Therapeutics$12K
  • Chiasma, Inc.$8K
  • Amryt Pharma Holdings Ltd$6K
  • Chiesi USA, Inc.$573

What the payments were for

  • Consulting fees$30,73558%
  • Speaking & faculty fees$15,25029%
  • Travel & lodging$2,3234%
  • Food & beverage$3,6437%
  • Education$620%
  • Entertainment$670%
  • Other$5551%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,635 in reported general payments places this provider in the 80th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024
$210,723
Medicare patients
365
Services billed
799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Santa Monica

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →